QTTB News
Archived Headlines
- US IPO Week Ahead: Largest Chinese deal since Alibaba leads 8-IPO week 03/23/18
- Rare disease biotech Homology Medicines sets terms for $100 million IPO 03/19/18
- US IPO Weekly Recap: Spotify files for a $1 billion non-IPO 03/02/18
- Gene therapy biotech Homology Medicines files for a $100 million IPO 03/02/18
Pushing preclinical: Wave of early-stage biotech IPOs tests investor risk appetite
Biotechs are among the most risky of IPOs due to the binary nature of the success… or failure of their drugs. In the past, most biotechs delayed public offerings until they at least showed clinical evidence of their safety or efficacy. But in 2018,...read more
US IPO Weekly Recap: 8-IPO week caps record 1Q with a flurry of Chinese deals
Eight US IPOs raised $3.3 billion this week, including four Chinese deals and three biotechs. iQIYI raised $2.3 billion, making it the largest Chinese IPO...read more
Preclinical gene therapy biotech Homology Medicines prices upsized IPO at $16 high end
Homology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, raised $144 million by offering 9 million shares at $16, the high end of the range of $14 to $16. It previously filed to offer 6.7 million shares at the same...read more
Gene therapy biotech Homology Medicines increases proposed IPO deal size ahead of pricing
Homology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, raised the proposed deal size for its upcoming IPO on Tuesday. The Bedford, MA-based company now plans to raise $135 million by offering 9 million...read more